Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
07 5월 2024 - 5:05AM
Business Wire
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage
biotechnology company developing an innovative drug delivery
technology designed to leverage a patient’s own biology to deliver
rare disease therapeutics, today announced that Dirk Thye, M.D.,
Quince’s Chief Executive Officer and Chief Medical Officer, will
present at The Citizens JMP Life Sciences Conference on Monday, May
13, 2024 beginning at 1:30 p.m. Eastern Time.
A live webcast of the presentation will be accessible on the
Events page under the News & Events heading of Quince’s
Investor Relations website at ir.quincetx.com. An archive of the
webcast will be available shortly following the end of the live
event.
About Quince Therapeutics
Quince Therapeutics (Nasdaq: QNCX) is a late-stage biotechnology
company dedicated to unlocking the potential of a patient’s own
biology to deliver innovative and life-changing therapeutics to
those living with rare diseases. For more information on the
company and its latest news, visit www.quincetx.com and follow
Quince Therapeutics on social media platforms LinkedIn, Facebook,
and Twitter/X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240506671205/en/
Media & Investor Contact: Stacy Roughan Quince
Therapeutics, Inc. Vice President, Corporate Communications &
Investor Relations ir@quincetx.com
Quince Therapeutics (NASDAQ:QNCX)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Quince Therapeutics (NASDAQ:QNCX)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
